Literature DB >> 360779

Comparative trial of amitriptyline-N-oxide and amitriptyline in the treatment of out-patients with depressive syndromes.

W Rapp.   

Abstract

Amitriptyline-N-oxide and amitriptyline were compared double-blind in a material of out-patients with depressive syndromes, 21 and 22 patients respectively. Both drugs had a good antidepressant effect. The globally rated effect was equal. The effect upon the various depressive symptoms was equal. Definite reversal of depression occurred somewhat earlier on amitriptyline-N-oxide on which side effects were also less marked, but those of an anticholinergic and of a sedative nature. No orthostatic reaction, nor any effect upon blood status or liver function was observed. Amitriptyline-N-oxide appears to show a tendency to a somewhat more rapid onset of effect and less side effects.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 360779     DOI: 10.1111/j.1600-0447.1978.tb06936.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  2 in total

1.  Self-rating data as a selecting factor in clinical trials of psychotropic drugs.

Authors:  U Baumann; F Eckmann; R D Stieglitz
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

Review 2.  The Relationship Between 5-Hydroxytryptamine and Its Metabolite Changes With Post-stroke Depression.

Authors:  Simeng Gu; Zhengming He; Qiuyue Xu; Jie Dong; Tingwei Xiao; Fei Liang; Xianjun Ma; Fushun Wang; Jason H Huang
Journal:  Front Psychiatry       Date:  2022-04-26       Impact factor: 5.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.